Zdrowie i gospodarka · 30/08/2019

FDA Releases Guidance on Uncertainty in Medical Device Benefit-Risk Determinations

The US Food and Drug Administration (FDA) has published a final guidance document outlining its approach to considering uncertainty in medical device premarket decisions, aiming to increase predictability and efficiency in the approval process.